MedPath

MINT-EPLERENONE

MINT-EPLERENONE

Approved
DIN Number

02471442

Drug Class

Human

Market Date

Apr 9, 2018

Company
HC

mint pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02471442
AIG Number0152537001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C03DA04 EPLERENONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

EPLERENONEActive
Strength: 25 MG
Monograph: EPLERENONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.